Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.36 Billion CNY | -7.74% |
| 2022 | 1.16 Billion CNY | 5.28% |
| 2021 | 1.1 Billion CNY | 18.25% |
| 2020 | 933.38 Million CNY | -19.34% |
| 2019 | 1.15 Billion CNY | 34.7% |
| 2018 | 859.09 Million CNY | 34.51% |
| 2017 | 638.69 Million CNY | 13.37% |
| 2016 | 563.39 Million CNY | 0.12% |
| 2015 | 562.71 Million CNY | 39.4% |
| 2014 | 403.67 Million CNY | 105.86% |
| 2013 | 196.09 Million CNY | 45.57% |
| 2012 | 134.7 Million CNY | 21.79% |
| 2011 | 110.6 Million CNY | 4.1% |
| 2010 | 106.24 Million CNY | 10.37% |
| 2009 | 96.25 Million CNY | 12.48% |
| 2008 | 85.57 Million CNY | -3.41% |
| 2007 | 88.6 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 228.29 Million CNY | -2.5% |
| 2024 Q3 | 176.03 Million CNY | 5.37% |
| 2024 Q2 | 220.85 Million CNY | -3.26% |
| 2023 Q3 | 272.74 Million CNY | -5.55% |
| 2023 Q4 | 234.15 Million CNY | -14.15% |
| 2023 Q1 | 276.37 Million CNY | -22.85% |
| 2023 FY | 1.07 Billion CNY | -7.74% |
| 2023 Q2 | 288.77 Million CNY | 4.49% |
| 2022 FY | 1.16 Billion CNY | 5.28% |
| 2022 Q1 | 294.67 Million CNY | 11.74% |
| 2022 Q4 | 358.24 Million CNY | 57.73% |
| 2022 Q3 | 227.12 Million CNY | -19.46% |
| 2022 Q2 | 281.99 Million CNY | -4.3% |
| 2021 Q3 | 301.2 Million CNY | 16.39% |
| 2021 FY | 1.1 Billion CNY | 18.25% |
| 2021 Q2 | 258.78 Million CNY | -7.59% |
| 2021 Q1 | 280.03 Million CNY | 85.16% |
| 2021 Q4 | 263.71 Million CNY | -12.45% |
| 2020 Q2 | 257.16 Million CNY | 25.12% |
| 2020 Q4 | 151.24 Million CNY | -52.65% |
| 2020 FY | 933.38 Million CNY | -19.34% |
| 2020 Q1 | 205.53 Million CNY | -46.19% |
| 2020 Q3 | 319.43 Million CNY | 24.21% |
| 2019 FY | 1.15 Billion CNY | 34.7% |
| 2019 Q3 | 290.41 Million CNY | 15.51% |
| 2019 Q1 | 233.36 Million CNY | -27.29% |
| 2019 Q4 | 381.97 Million CNY | 31.53% |
| 2019 Q2 | 251.41 Million CNY | 7.74% |
| 2018 FY | 859.09 Million CNY | 34.51% |
| 2018 Q3 | 205.09 Million CNY | 16.85% |
| 2018 Q1 | 157.54 Million CNY | -28.79% |
| 2018 Q2 | 175.51 Million CNY | 11.41% |
| 2018 Q4 | 320.93 Million CNY | 56.48% |
| 2017 Q4 | 221.25 Million CNY | 70.09% |
| 2017 Q2 | 146.57 Million CNY | 4.1% |
| 2017 FY | 638.69 Million CNY | 13.37% |
| 2017 Q1 | 140.79 Million CNY | -20.75% |
| 2017 Q3 | 130.07 Million CNY | -11.25% |
| 2016 FY | 563.39 Million CNY | 0.12% |
| 2016 Q4 | 177.66 Million CNY | 59.97% |
| 2016 Q1 | 140.34 Million CNY | -23.38% |
| 2016 Q2 | 134.33 Million CNY | -4.28% |
| 2016 Q3 | 111.05 Million CNY | -17.33% |
| 2015 Q3 | 133.19 Million CNY | 4.79% |
| 2015 Q1 | 119.25 Million CNY | -22.88% |
| 2015 Q2 | 127.09 Million CNY | 6.58% |
| 2015 FY | 562.71 Million CNY | 39.4% |
| 2015 Q4 | 183.17 Million CNY | 37.53% |
| 2014 Q2 | 82.15 Million CNY | 17.72% |
| 2014 FY | 403.67 Million CNY | 105.86% |
| 2014 Q4 | 154.62 Million CNY | 59.22% |
| 2014 Q3 | 97.11 Million CNY | 18.21% |
| 2014 Q1 | 69.78 Million CNY | -20.85% |
| 2013 Q2 | 28.96 Million CNY | -28.77% |
| 2013 Q3 | 38.28 Million CNY | 32.16% |
| 2013 Q1 | 40.66 Million CNY | -20.13% |
| 2013 Q4 | 88.17 Million CNY | 130.31% |
| 2013 FY | 196.09 Million CNY | 45.57% |
| 2012 Q4 | 50.91 Million CNY | 72.69% |
| 2012 FY | 134.7 Million CNY | 21.79% |
| 2012 Q2 | 22.74 Million CNY | -27.92% |
| 2012 Q3 | 29.48 Million CNY | 29.64% |
| 2012 Q1 | 31.55 Million CNY | -18.84% |
| 2011 Q3 | 24.65 Million CNY | 5.64% |
| 2011 Q1 | 23.73 Million CNY | -17.72% |
| 2011 Q2 | 23.33 Million CNY | -1.65% |
| 2011 Q4 | 38.87 Million CNY | 57.69% |
| 2011 FY | 110.6 Million CNY | 4.1% |
| 2010 Q2 | 21.87 Million CNY | -21.61% |
| 2010 Q4 | 28.84 Million CNY | 4.43% |
| 2010 Q3 | 27.61 Million CNY | 26.23% |
| 2010 FY | 106.24 Million CNY | 10.37% |
| 2010 Q1 | 27.9 Million CNY | 4.9% |
| 2009 Q3 | 20.71 Million CNY | 0.0% |
| 2009 Q4 | 26.6 Million CNY | 28.42% |
| 2009 FY | 96.25 Million CNY | 12.48% |
| 2008 FY | 85.57 Million CNY | -3.41% |
| 2007 FY | 88.6 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 4.78 Billion CNY | 71.512% |
| ZJAMP Group Co., Ltd. | 1.31 Billion CNY | -3.563% |
| Luyan Pharma Co.,Ltd. | 1.03 Billion CNY | -31.329% |
| Ji Yao Holding Group Co., Ltd. | 428.47 Million CNY | -218.132% |